Advertisement

Why perform pelvic exenteration when cure is not an option?

  • Peter C. Ambe
    Correspondence
    Corresponding author. Department of General, Visceral and Colorectal Surgery, GFO Kliniken Rhein Berg, Germany.
    Affiliations
    Department of Medicine, Witten/Herdecke Univesity, Witten, Germany
    Department of General, Visceral and Colorectal Surgery, GFO Kliniken Rhein Berg, Germany
    Search for articles by this author
Published:September 03, 2022DOI:https://doi.org/10.1016/j.ejso.2022.08.027
      Pelvic exenteration represents a maximally radical procedure for the management of pelvic malignancies. Because the risk of morbidity following pelvic exenteration is very high, this procedure in my opinion should be reserved for patients being management with a curative intension. The benefit of this extensive and partly disfiguring surgery, i.e. potential cure of a malignant disease must be weighed against the risk of complications.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nielsen C.K.P.
        • Sørensen M.M.
        • Christensen H.K.
        • Funder J.A.
        Complications and survival after total pelvic exenteration.
        Eur J Surg Oncol. 2022;
        • Collaborative P.
        • Kelly M.
        • Aalbers A.
        • Abdul Aziz N.
        • Abecasis N.
        • Abraham-Nordling M.
        • et al.
        Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
        Colorectal Dis. 2020; 22: 1258-1262

      Linked Article